Начало・Списък с акции・Pharma Mar SA

P
Pharma Mar SA

Затворен

76.55 -2.05

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

76.2

Максимум

78.85

Ключови измерители
By Trading Economics
Приходи	-2.6M -993K
Продажби	6.7M 50M
P/E Средно за сектора	25.435 56.597
EPS	-0.056
Дивидентна доходност	1.22
Марж на печалбата	-2.002
Служители	505
EBITDA	-2.7M 9K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+25% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	1.22% 2.18%
Следващи печалби	29.10.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	41M 1.4B
Предишно отваряне	78.6
Предишно затваряне	76.55

Pharma Mar SA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.09.2026 г., 23:56 ч. UTC

Revolve Group Inc shares are higher in after-market hours, maintaining an upward trend since Wednesday's close, despite being below the 20-day moving average.

9.09.2026 г., 23:56 ч. UTC

Correlated Moves

Procore Technologies Inc shares are higher in after-market hours, recovering from an initial decline. The stock remains below its 20-day moving average.

9.09.2026 г., 23:56 ч. UTC

BlackLine Inc. shares rose in after-market trading, recovering from an initial dip. The stock remains below its 20-day moving average amid broader market challenges.

9.09.2026 г., 23:56 ч. UTC

MetLife Inc shares are lower in after-market hours amid heightened market anxiety over geopolitical tensions and upcoming economic data releases.

9.09.2026 г., 23:56 ч. UTC

Warner Bros Discovery Inc. shares are higher in after-market trading, despite earlier fluctuations and amid broader market anxiety over geopolitical tensions and economic data.

9.09.2026 г., 23:56 ч. UTC

JinkoSolar Holding Co Ltd shares are lower in after-market hours, continuing a decline amid market anxiety over geopolitical tensions and upcoming economic data releases.

9.09.2026 г., 23:56 ч. UTC

No specific news was identified for Solaredge Technologies. Shares traded roughly flat in after-market hours, remaining near the upper end of their one-month range.

9.09.2026 г., 23:53 ч. UTC

Gossamer Bio Inc. shares are lower in after-market hours following a significant decline since Wednesday's close, despite an earlier attempt to recover.

9.09.2026 г., 23:52 ч. UTC

ACI Worldwide shares declined in after-market trading, continuing a downward trend from regular trading and reflecting ongoing selling pressure amid broader market conditions.

9.09.2026 г., 23:52 ч. UTC

The NZD/CHF is trading lower during Wednesday's session, reflecting routine movement near its one-month trading range's lower end. No specific news was identified.

9.09.2026 г., 23:51 ч. UTC

Correlated Moves

Ares Management shares are higher in after-market trading, reflecting positive market conditions and aligning with upward trends in correlated assets like Brookfield Corp.

9.09.2026 г., 23:51 ч. UTC

Correlated Moves

ACNB Corp shares are lower in after-market hours, continuing a trend of declining performance amid broader market pressures and rising crude oil prices.

9.09.2026 г., 23:51 ч. UTC

News

Toll Brothers Inc. shares are lower in after-market trading, continuing a trend of declining performance amid broader market pressures and rising crude oil prices.

9.09.2026 г., 23:51 ч. UTC

Lamb Weston Holdings Inc shares are higher in after-market hours, reflecting an increase since Wednesday's close, despite recent underperformance and no specific news identified.

9.09.2026 г., 23:51 ч. UTC

ManpowerGroup Inc. shares are lower in after-market hours, continuing a decline below the 20-day moving average amid broader market weakness.

9.09.2026 г., 23:51 ч. UTC

MVB Financial Corp shares traded higher in after-market hours, reaching 0.42% above Wednesday's close and remaining above their 20-day moving average.

9.09.2026 г., 23:51 ч. UTC

Travelers Companies Inc shares are higher in after-market hours, reaching a peak return after an initial dip. No specific news was identified for this movement.

9.09.2026 г., 23:51 ч. UTC

Movado Group Inc shares are lower in after-market hours, continuing a decline since Wednesday's close and remaining below the 20-day moving average.

9.09.2026 г., 23:51 ч. UTC

UK Housing Market Shows Signs of Stabilization with Slight Improvement in House Price Balance, Amidst Cautious Optimism and Ongoing Economic Challenges

9.09.2026 г., 23:51 ч. UTC

Existing Home Sales Expected to Decline Amid High Mortgage Rates and Decreased Buyer Demand

9.09.2026 г., 23:51 ч. UTC

US Existing Home Sales Data for August 2026 Expected at 3.98 Million Amid Rising Inventory and High Mortgage Rates.

9.09.2026 г., 23:51 ч. UTC

Brazil's Central Bank Faces Critical Interest Rate Decision Amid Inflation Concerns and Economic Resilience on September 16, 2026.

9.09.2026 г., 23:51 ч. UTC

Chubb Limited shares are lower in after-market hours, continuing a trend of declining prices. The stock is below its 20-day moving average.

9.09.2026 г., 23:51 ч. UTC

Amerisafe Inc shares are higher after market hours, despite a slight decline earlier. The stock remains below its 20-day moving average.

9.09.2026 г., 23:51 ч. UTC

Correlated Moves

Carlyle Group Inc is trading higher in after-market hours, rebounding from three consecutive lower sessions amid broader positive market dynamics despite rising crude oil prices.

9.09.2026 г., 23:51 ч. UTC

Patrick Industries Inc. shares declined after market hours, continuing a trend of lower closes. The stock remains significantly below the 20-day moving average.

9.09.2026 г., 23:51 ч. UTC

News

Lakeland Industries reported a fiscal Q2 net loss of $4.9 million and lower-than-expected sales, leading shares to decline in after-market trading.

9.09.2026 г., 23:51 ч. UTC

News

Limoneira Co reported third-quarter results that missed expectations, with revenues falling to $43.8 million and shares trading lower in after-market hours.

9.09.2026 г., 23:51 ч. UTC

Correlated Moves

EUR/CHF is trading higher, recovering from earlier lows and reflecting unusual intraday activity near the upper end of its one-month range.

9.09.2026 г., 23:51 ч. UTC

GBP/CHF is trading higher during Wednesday's session, recovering from an early dip and settling near the upper end of its one-month trading range.

Сравнение с други в отрасъла

Ценова промяна

Pharma Mar SA Прогноза

Ценова цел

By TipRanks

25% нагоре

12-месечна прогноза

Среден 100 EUR 25%

Висок 100 EUR

Нисък 100 EUR

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Pharma Mar SA през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Pharma Mar SA през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.